Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Celcuity Inc banner
C

Celcuity Inc
NASDAQ:CELC

Watchlist Manager
Celcuity Inc
NASDAQ:CELC
Watchlist
Price: 65.35 USD 0.15% Market Closed
Market Cap: $3.2B
Write Note Create Alert Ask AI

Intrinsic Value

Not Available for CELC

There is not enough data to reliably calculate the intrinsic value for Celcuity Inc.

Do our valuations actually work? See backtest results .

Alternatives to CELC

Fundamental Analysis

What Celcuity Does

Biotechnology Health Care

Celcuity Inc. is a clinical-stage biotechnology company that develops cancer drugs aimed at specific tumor signaling pathways. Its main work is to identify which patients are most likely to respond to a treatment and then advance drugs that block the biological signals helping cancer cells grow. The company’s lead programs are built around targeted therapies rather than broad chemotherapy, so its business depends on matching the right drug to the right cancer biology.

Headquarters
United States of America US
Employees
155
IPO date
Sep 20, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Celcuity Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

CELC Insider Trading
Buy and sell transactions by insiders

Continue CELC Research

Summary
CELC intrinsic value, competitors valuation, and company profile.
DCF Valuation
CELC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CELC stock valuation using valuation multiples.
Wall St Estimates
CELC price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CELC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join 362,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.